
by Fatemeh Rahmatabadi: This week’s journal club focuses on a study from Drugs in R&D (2024) aiming to assess the activity of trametinib against a panel of tumor cells from patients with AML
9/23/2025 Georg
9/30/2025 Thomas
10/7/2025 Kayko
10/14/2025 Shayla
10/21/2025 Agnes
10/28/2025 Fatemeh
11/4/2025 Lucas
11/11/2025 Ulrik